| |
Psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, is moving through one of the most closely watched areas of psychiatric research. As clinical trials continue to study its potential role in treatment-resistant depression, many patients and families are wondering what FDA approval could mean — and how soon new options may become available.
In our latest blog, Psyche Denver looks at the 2026 timeline for psilocybin FDA approval, recent clinical trial progress, and the practical realities of bringing this type of treatment into regulated mental health care. While the research is promising, psilocybin is not currently FDA-approved for psychiatric treatment, and Psyche Denver does not recommend anyone pursue it unless and until it receives FDA approval, even in places where it may be legal.
For those following the future of depression treatment, this article offers a clear, grounded look at what is changing, what still needs to happen, and why medical oversight matters.
👉 Read the Blog
|
|
| Curious About Emerging Mental Health Treatments? |
If you’re exploring advanced options for depression, anxiety, or treatment-resistant symptoms, Psyche Denver can help you understand what is available today and what remains under clinical investigation. |
|
| |  |
I came here 6 years ago and was so severely depressed I was unable to do daily tasks. [They] kept at it until I was stable and than continued to help me to achieve stable mental health. Do yourself a favor and go and see [them]. The office staff are fabulous as well.
Patient,
Christine W. |
|
The staff is great and they have helped me through a rough period of my life. They assisted me in getting on prescription assistance and with prior authorizations with the insurance company. Everyone is very straight forward about cost and what my insurance will cover... Big thank you to everyone who helped me get to where I am right now. It is a lot of work, but it works if you honestly try to participate in your own recovery. One day, one hour, even 1 second at a time.
Patient, Chris G. |  |
|
|
|
|
About Psyche PCAdvanced Psychiatric Care. Collaborative Approach. |
|
| Psyche PC was founded by Dr. Jeffrey Richmond, a board-certified psychiatrist dedicated to helping adults access innovative, evidence-based psychiatric care in Colorado.
Our practice provides medication management, Spravato® (Esketamine), and transcranial magnetic stimulation (TMS) for patients experiencing treatment-resistant mental health conditions. We do not offer psychotherapy, but we work collaboratively with referring providers to support each patient’s treatment plan and continuity of care.
As new psychiatric treatments continue to move through research and regulatory review, Psyche Denver remains focused on what patients can safely access now: compassionate, clinically guided care delivered in a professional setting. |
|
|
We’re proud to support psychiatrists, therapists, primary care providers, and patients across Colorado.
🧑⚕️ Now accepting new patients 🏥 In-person care at our Denver office 💻 Virtual visits for Colorado residents |
| Get to Know Psyche PC |
|
|
|
